Skip to main content
SpringerLink
Log in

Is Prostate Cancer a Good Candidate for Ion Beam Therapy?

  • Chapter
  • First Online:
Ion Beam Therapy

Part of the book series: Biological and Medical Physics, Biomedical Engineering ((BIOMEDICAL,volume 320))

  • 1990 Accesses

Abstract

Organ-confined prostate cancer now constitutes one of the most commonly treated malignancies with ion beam therapy (IBT). Because of this, questions have been raised regarding the efficacy and cost-effectiveness of such treatment. This chapter details the clinical results obtained with both proton and carbon ion therapy, discusses ongoing clinical trials, and seeks to place IBT in the context of other technological evolutions in radiation oncology.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. American Cancer Society, Surveillance and Health Policy Research, Cancer Facts and Figures 2010, http://www.cancer.org/Research/CancerFactsFigures/CancerFactsFigures/cancer-facts-and-figures-2010

  2. P. Bergstrom, P.O. Lofroth, A. Widmark, High-precision conformal radiotherapy (HPCRT) of prostate cancer-a new technique for exact positioning of the prostate at the time of treatment. Int. J. Radiat. Oncol. Biol. Phys. 42, 305–311 (1998)

    Google Scholar 

  3. P. Bey, C. Carrie, V. Beckendorf, et al., Dose escalation with 3D-CRT in prostate cancer: French study of dose escalation with conformal 3D radiotherapy in prostate cancer-preliminary results. Int. J. Radiat. Oncol. Biol. Phys. 48, 513–517 (2000)

    Article  Google Scholar 

  4. M. Bolla, What is the role of radiation dose escalation in the treatment of localized prostate cancer? Nat. Clin. Pract. Urol. 5, 418–419 (2008)

    Article  Google Scholar 

  5. R. Cheung, S.L. Tucker, L. Dong, et al., Dose-response for biochemical control among high-risk prostate cancer patients after external beam radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 56, 1234–1240 (2003)

    Article  Google Scholar 

  6. G. Goldner, J. Dimopoulos, C. Kirisits, et al., Moderate dose escalation in three-dimensional conformal localized prostate cancer radiotherapy: single-institutional experience in 398 patients comparing 66 Gy versus 70 Gy versus 74 Gy. Strahlenther. Onkol. 185, 438–445 (2009)

    Article  Google Scholar 

  7. M.J. Zelefsky, Y. Yamada, Z. Fuks, et al., Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes. Int. J. Radiat. Oncol. Biol. Phys. 71, 1028–1033 (2008)

    Article  Google Scholar 

  8. J.O. Archambeau, G.W. Bennett, S.T. Chen, Potential of proton beams for total nodal irradiation. Acta Radiol. Ther. Phys. Biol. 13, 393–401 (1974)

    Article  Google Scholar 

  9. B. Arjomandy, N. Sahoo, J. Cox, et al., Comparison of surface doses from spot scanning and passively scattered proton therapy beams. Phys. Med. Biol. 54, N295–N302 (2009)

    Article  ADS  Google Scholar 

  10. J.S. Loeffler, A.R. Smith, H.D. Suit, The potential role of proton beams in radiation oncology. Semin. Oncol. 24, 686–695 (1997)

    Google Scholar 

  11. H.D. Suit, M. Urie, Proton beams in radiation therapy. J. Natl. Cancer Inst. 84, 155–164 (1992)

    Article  Google Scholar 

  12. U. Amaldi, Conformal radiation therapy with hadron beams and the programs of the TERA Foundation. Rays 23, 486–507 (1998)

    Google Scholar 

  13. A. Konski, W. Speier, A. Hanlon, et al., Is proton beam therapy cost effective in the treatment of adenocarcinoma of the prostate? J. Clin. Oncol. 25, 3603–3608 (2007)

    Article  Google Scholar 

  14. M.L. Steinberg, A. Konski, Proton beam therapy and the convoluted pathway to incorporating emerging technology into routine medical care in the United States. Cancer J. 15, 333–338 (2009)

    Article  Google Scholar 

  15. W.U. Shipley, J.E. Tepper, G.R. Prout, et al., Proton radiation as boost therapy for localized prostatic carcinoma. J. Am. Med. Assoc. 241, 1912–1915 (1979)

    Article  Google Scholar 

  16. W.U. Shipley, L.J. Verhey, J.E. Munzenrider, et al., Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone. Int. J. Radiat. Oncol. Biol. Phys. 32, 3–12 (1995)

    Article  Google Scholar 

  17. G.E. Hanks, A question-filled future for dose escalation in prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 32, 267–269 (1995)

    Article  ADS  Google Scholar 

  18. T. Wiegel, W. Hinkelbein, Lokal fortgeschrittenes Prostatakarzinom (T2b-T4 N0) ohne und lokoregionär fortgeschrittenes Prostatakarzinom (Tx N + ) mit Lymphknotenmetastasen. Ist eine Strahlentherapie der pelvinen Lymphabflußwege indiziert oder nicht indiziert? Strahlenther. Onkol. 174, 231–236 (1998)

    Google Scholar 

  19. M. Roach 3rd, Neoadjuvant total androgen suppression and radiotherapy in the management of locally advanced prostate cancer. Semin. Urol. Oncol. 14, S32–S37, discussion S38, (1996)

    Google Scholar 

  20. M. Roach 3rd, Neoadjuvant therapy prior to radiotherapy for clinically localized prostate cancer. Eur. Urol. 32, S48–S54 (1997)

    Google Scholar 

  21. M. Roach 3rd, Current status of androgen suppression and radiotherapy for patients with prostate cancer. J. Steroid Biochem. Mol. Biol. 69, 239–245 (1999)

    Article  Google Scholar 

  22. M. Roach 3rd, Neoadjuvant hormonal therapy in men being treated with radiotherapy for localized prostate cancer. Rev. Urol. 6, S24–S31 (2004)

    Google Scholar 

  23. C.J. Rossi, J.D. Slater, N. Reyes-Molyneux, et al., Particle beam radiation therapy in prostate cancer: is there an advantage? Semin. Radiat. Oncol. 8, 115–123 (1998)

    Article  Google Scholar 

  24. J.M. Slater, The proton treatment center at Loma Linda University Medical Center: rationale for and description of its development. Int. J. Radiat. Oncol. Biol. Phys. 22, 383–389 (1992)

    Article  Google Scholar 

  25. J.D. Slater, L.T. Yonemoto, C.J. Rossi, et al., Conformal proton therapy for prostate carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 42, 299–304 (1998)

    Google Scholar 

  26. J.D. Slater, C.J. Rossi, L.T. Yonemoto, et al., Proton therapy for prostate cancer: the initial Loma Linda University experience. Int. J. Radiat. Oncol. Biol. Phys. 59, 348–352 (2004)

    Article  Google Scholar 

  27. A.L. Zietman, M.L. DeSilvo, J.D. Slater, et al., Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. J. Am. Med. Assoc. 294, 1233–1239 (2005)

    Article  Google Scholar 

  28. M.C. Abramowitz, T. Li, M.K. Buyyounouski, et al., The Phoenix definition of biochemical failure predicts for overall survival in patients with prostate cancer. Cancer 112, 55–60 (2008)

    Article  Google Scholar 

  29. A.L. Zietman, K. Bae, J.D. Slater, et al., Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/American College of Radiology 95–09. J. Clin. Oncol. 28, 1106–1111 (2010)

    Article  Google Scholar 

  30. J.A. Talcott, C.J. Rossi, W.U. Shipley, et al., Patient-reported long-term outcomes after conventional and high-dose combined proton and photon radiation for early prostate cancer. J. Am. Med. Assoc. 303, 1046–1053 (2010)

    Article  Google Scholar 

  31. N.P. Mendenhall, Z. Lin, C.G. Morris, et al., Early GI and GU toxicity in three prospective trials of proton therapy for prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 75, S11–S12 (2009)

    Article  Google Scholar 

  32. I. Hara, M. Murakami, K. Kagawa, et al., Experience with conformal proton therapy for early prostate cancer. Am. J. Clin. Oncol. 27, 323–327 (2004)

    Article  Google Scholar 

  33. H. Mayahara, M. Murakami, K. Kagawa, et al., Acute morbidity of proton therapy for prostate cancer: the Hyogo Ion Beam Medical Center experience. Int. J. Radiat. Oncol. Biol. Phys. 69, 434–443 (2007)

    Article  Google Scholar 

  34. J.F. Fowler, The radiobiology of prostate cancer including new aspects of fractionated radiotherapy. Acta Oncol. 44, 265–276 (2005)

    Article  Google Scholar 

  35. I.J. Constable, Proton irradiation therapy for ocular melanoma. Trans. Ophthalmol. Soc. UK 97, 430 (1977)

    Google Scholar 

  36. E.S. Gragoudas, M. Goitein, L. Verhey, et al., Proton beam irradiation of uveal melanomas. Results of 5 1/2-year study. Arch. Ophthalmol. 100, 928–934 (1982)

    Google Scholar 

  37. J.E. Munzenrider, M. Austin-Seymour, P.J. Bitzer, et al., Proton therapy at Harvard. Strahlentherapie 161, 756–763 (1985)

    Google Scholar 

  38. R.P. Levy, J.I. Fabrikant, K.A. Frankel, et al., Charged-particle radiosurgery of the brain. Neurosurg. Clin. N. Am. 1, 955–990 (1990)

    Google Scholar 

  39. G.K. Steinberg, J.I. Fabrikant, M.P. Marks, et al., Stereotactic heavy-charged-particle Bragg-peak radiation for intracranial arteriovenous malformations. N. Engl. J. Med. 323, 96–101 (1990)

    Article  Google Scholar 

  40. D.A. Bush, J.D. Slater, R. Bonnet, et al., Proton-beam radiotherapy for early-stage lung cancer. Chest 116, 1313–1319 (1999)

    Article  Google Scholar 

  41. D.A. Bush, J.D. Slater, C. Gerberoglio, et al., A technique of partial breast irradiation utilizing proton beam radiotherapy: comparison with conformal x-ray therapy. Cancer J. 13, 114–118 (2007)

    Article  Google Scholar 

  42. D.J. Brenner, Hypofractionation for prostate cancer radiotherapy – what are the issues? Int. J. Radiat. Oncol. Biol. Phys. 57, 912–914 (2003)

    Article  Google Scholar 

  43. P.A. Kupelian, V.V. Thakkar, D. Khunita, et al., Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: long-term outcomes. Int. J. Radiat. Oncol. Biol. Phys. 63, 1463–1468 (2005)

    Google Scholar 

  44. P.A. Kupelian, T.R. Willoughby, C.A. Reddy, et al., Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience. Int. J. Radiat. Oncol. Biol. Phys. 68, 1424–1430 (2007)

    Google Scholar 

  45. V. Macias, A. Biete, Hypofractionated radiotherapy for localised prostate cancer – Review of clinical trials. Clin. Transl. Oncol. 11, 437–445 (2009)

    Article  Google Scholar 

  46. G. Soete, S. Arcangeli, G. De Meerleer, et al., Phase II study of a four-week hypofractionated external beam radiotherapy regimen for prostate cancer: report on acute toxicity. Radiother. Oncol. 80, 78–81 (2006)

    Article  Google Scholar 

  47. J.F. Fowler, A.E. Nahum, C.G. Orton, Point/Counterpoint. The best radiotherapy for the treatment of prostate cancer involves hypofractionation. Med. Phys. 33, 3081–3084 (2006)

    Google Scholar 

  48. D.A. Kuban, S.L. Tucker, L. Dong, et al., Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 70, 67–74 (2008)

    Google Scholar 

  49. G.T. Chen, J.R. Castro, J.M. Quivey, Heavy charged particle radiotherapy. Annu. Rev. Biophys. Bioeng. 10, 499–529 (1981)

    Article  Google Scholar 

  50. J. Debus, O. Jäckel, G. Kraft, et al., Is there a role for heavy ion beam therapy? Recent Results Cancer Res. 150, 170–182 (1998)

    Article  Google Scholar 

  51. H. Engels, A. Wambersie, Relative biological effectiveness of neutrons for cancer induction and other late effects: a review of radiobiological data. Recent Results Cancer Res. 150, 54–87 (1998)

    Article  Google Scholar 

  52. E. Fokas, G. Kraft, H. An, et al., Ion beam radiobiology and cancer: time to update ourselves. Biochim. Biophys. Acta 1796, 216–229 (2009)

    Google Scholar 

  53. E.J. Hall, The particles compared. Int. J. Radiat. Oncol. Biol. Phys. 8, 2137–2140 (1982)

    Article  Google Scholar 

  54. C.A. Tobias, E.A. Blakely, E.L. Alpen, et al., Molecular and cellular radiobiology of heavy ions. Int. J. Radiat. Oncol. Biol. Phys. 8, 2109–2120 (1982)

    Article  Google Scholar 

  55. H. Ishikawa, H. Tsuji, H. Tsujii, Clinical experience of carbon ion radiotherapy for malignant tumors (Article in Japanese). Gan To Kagaku Ryoho 33, 444–449 (2006)

    Google Scholar 

  56. H. Suit, H. Kooy, A. Trofimov, et al., Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No. Radiother. Oncol. 86, 148–153 (2008)

    Article  Google Scholar 

  57. H. Suit, The Gray Lecture 2001: coming technical advances in radiation oncology. Int. J. Radiat. Oncol. Biol. Phys. 53, 798–809 (2002)

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Medicine, Loma Linda University Medical Center, 11234 Anderson Street, CSP A-1010, Loma Linda, CA, 92354, USA

    Carl J. Rossi Jr.

Authors
  1. Carl J. Rossi Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Carl J. Rossi Jr. .

Editor information

Editors and Affiliations

  1. Forschungszentrum Jülich, Jülich, 52425, Germany

    Ute Linz

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Rossi, C.J. (2012). Is Prostate Cancer a Good Candidate for Ion Beam Therapy?. In: Linz, U. (eds) Ion Beam Therapy. Biological and Medical Physics, Biomedical Engineering, vol 320. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-21414-1_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-21414-1_16

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-21413-4

  • Online ISBN: 978-3-642-21414-1

  • eBook Packages: Physics and AstronomyPhysics and Astronomy (R0)

Publish with us

Policies and ethics

Search

Navigation